Effects of some anti-neoplastic drugs on sheep liver sorbitol dehydrogenase

Archives of Physiology and Biochemistry

Volumn 118, Issue 5, 2012, Pages 244-252

  Alim, Zuhal ^a   Beydemir, Şükrü ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Lantineoplastic drugs; Linhibition; Liver; Lsorbitol dehydrogenase; Polyol pathways

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; IDITOL DEHYDROGENASE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME STABILITY; ENZYMOLOGY; IC 50; ISOLATION AND PURIFICATION; LIVER; MOLECULAR WEIGHT; OXIDATIVE STRESS; PRECIPITATION; RAT; SHEEP;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEMICAL PRECIPITATION; ENZYME INHIBITORS; ENZYME STABILITY; INHIBITORY CONCENTRATION 50; L-IDITOL 2-DEHYDROGENASE; LIVER; MOLECULAR WEIGHT; OXIDATIVE STRESS; RATS; SHEEP;

OVIS ARIES;

EID: 84869420951     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2012.688055     Document Type: Article

References (60)

1. Abdel-Hamid NM, Nazmy MH, Abdel-Bakey AI. (2011). Polyol profle as an early diagnostic and prognostic marker in natural product chemoprevention of hepatocellular carcinoma in diabetic rats. Diabetes Res Clin Pr 92:228-37.
2. Alici HA, Ekinci D, Beydemir Ş. (2008). Intravenous anesthetics inhibit human paraoxonase-1 (PON1) activity in vitro and in vivo. Clin Biochem 41:1384-1390.
3. Andrews P. (1965). Te gel fltration behaviour of proteins related to their molecular weights over a wide range. Biochem J 96:595-606.
4. Banfeld MJ, Salvucci ME, Baker EN, Smith CA. (2001). Crystal structure of the NADP(H)-dependent ketose reductase from Bemisia argentifolii at 2, 3 A resolution. J Mol Biol 306:239-50.
5. Beydemir Ş, Kufrevioglu OI, Ciftci M. (2003). Glucose 6-phosphate dehydrogenase: In vitro and in vivo efects of dantrolene sodium. Pol J Pharmacol 55:787-92.
6. Beydemir Ş (2004). Efects of melatonin on carbonic anhydrase from human erythrocytes in vitro and from rat erythrocytes in vivo. J Enzym Inhib Med Chem 19:193-97.
7. Bradford MM. (1976). A rapid and sensitive method for the quantition of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-51.
8. Brakley RL. (1951). Te metabolism and antiketogenic efects of sorbitol. Sorbitol dehydrogenase. Biochem J 49:257-71.
9. Brownlee M. (1992). Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15:1835-43.
10. Chu-Moyer MY, Ballinger WE, Beebe DA, Berger R, Couther JB, Day WW, Li J, Mylari BL, Oates PJ, Weekly RM. (2002). Orally-efective, long-acting sorbitol dehydrogenase inhibitors: synthesis, structure-activity relationships, and in vivo evaluations of novel heterocycle-substituted piperozine-pyrimidines. J Med Chem 45:511-28.
11. Coban TA, Beydemir St;, Ekinci D. (2007). Morphine inhibits erythrocyte carbonic anhydrase in vitro and in vivo. Biol Pharm Bull 30:2257-61.
12. Darmanin C, Iwata T, Carper DA, Sparrow LG, Chung RPT, El-Kabbani O. (2003). Expression, purifcation and preliminary crystallographic analysis of human sorbitol dehydrogenase. Acta Crystallogr D Biol Crystallogr 59:558-60.
13. Doehlert DC. (1987). Ketose reductase activity in developing maize endosperm. Plant Physiol 84:830-34.
14. Ekinci D, Beydemir St;, Alim Z. (2007). Some drugs inhibit in vitro hydratase and esterase activities of human carbonic anhydrase-I and II. Pharmacol Rep 59:580-87.
15. Ekinci D, Beydemir St;. (2010). Purifcation of PON1 from human serum and assessment of enzyme kinetics against metal toxicity. Biol Trace Elem Res 135:112-20.
16. Estonius M, Danielsson O, Karlsson C, Persson H, Jörnvall H, Höög JO. (1993). Distribution of alcohol and sorbitol dehydrogenases: assessment of mRNAs in rat tissues. Eur J Biochem 215:497-503.
17. Geissen K, Utz R, Grotsch H, Lang HJ, Nimmesgern H. (1994). Sorbitol accumulating pyrimidine derivatives. Arzneimittelforschung 44:1032-43.
18. Grandhee SK, Monnier VM. (1991). Mechanism of formation of the Maillard protein cross link pentosidine. Glucose, fructose and ascorbate as pentosidine precursors. J Biol Chem 266:11649-53.
19. Beydemir St;, Coban TA, Ekinci D. (2008). Te inhibitory efect of dantrolene sodium and propofol on 6-phosphogluconate dehydrogenase from rat erythrocyte. Fresen Environ Bull 17:1283-7.
20. Hamada Y, Araki N, Horiuchi S, Hotta N. (1996). Role of poliol pathway in nonenzymatic glycation. Nephrol Dial Transplant 11:5-95.
21. Hamada Y, Nakamura J, Naruse K, Komori T, Kato K, Kasuya Y, Nagai R, Horiuchis HN. (2000). Epalrestat, an aldose reductase inhibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care 23:1539-44.
22. Hisar O, Beydemir St, Hisar SA, Yanik T, Kufrevioglu OI. (2005). Te efects of melatonin hormone on carbonic anhydrase enzyme activity in rainbow trout (Oncorhynchus mykiss) erythrocytes in vitro and in vivo. Turk J Vet Anim Sci 29:841-5.
23. Israël M, Schwartz L. (2011). On the metabolic origin of cancer: Substances that target tumor metabolism. Biomed Res 22:130-64
24. ISt;gör MM, Beydemir St;. (2010). Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum. Eur J Pharmacol 645:135-42.
25. Jefery J, Chesters J, Mills C, Sadler PJ, Jornvall H. (1984). Sorbitol dehydrogenase is a zinc enzyme. EMBO J 3:357-60.
26. Karacaoǧlan V, Özer I. (2005). Steady-state kinetic properties of sorbitol dehydrogenase from chicken liver. Comp Biochem and Phys 140:309-12.
27. Karlsson C, Jornvall H, Höög JO. (1995). Zinc binding of alcohol and sorbitol dehydrogenase. Enzymology and Molecular Biology of Carbonyl Metabolism. New York: Plenum Press, 5:397-406.
28. Lee AY, Chung SS. (1999). Contributions of poliol pathway to oxidative stress in diabetic cataract. Faseb J 13:23-30.
29. Lindstad RI, Hermansen LF, McKinley-McKee JS. (1994). Inhibition and activation studies on sheep liver sorbitol dehydrogenase. Eur J Biochem 221:847-54.
30. Lindstad RI, Koll P, McKinley-McKee JS. (1998). Substrate specifcity of sheep liver sorbitol dehydrogenase. Biochem J 330:479-87.
31. Lindstad RI, McKinley-McKee JS. (1996). Reversible inhibition of sheep liver sorbitol dehydrogenase by thiol compounds. Eur J Biochem 241:142-48.
32. Lindstad RI, McKinley-McKee JS. (1997). Reversible inhibition of sheep liver sorbitol dehydrogenase by the antidiabetogenic drug 2-hydroxymethyl-4-(4- N, N-dimethylaminosulfonyl-1-piperazino) pyrimidine. FEBS Lett 408:57-61.
33. Linstad RI, Hermansen LF, McKinley-McKee JS. (1992). Te kinetic mechanism of sheep liver sorbitol dehydrogenase. Eur J Biochem 210:641-7.
34. Llovet JM, Bruix J. (2003). Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429-42.
35. Maekawa K, Tanimato T, Okada S, Suzuki T, Yabe-Nishimura C. (2001). Expression of aldose reductase and sorbitol dehydrogenase genes in Schwann cells isolated from rat: Efects of high glucose and osmotic stress. Mol Brain Res 87:251-6.
36. Marini I, Bucchioni L, Borella P, Del Corsa A, Mura U. (1997). Sorbitol dehydrogenase from bovine lens: purifcation and properties. Arch Biochem Biophys 340:383-91.
37. Maritim AC, Sanders III RA, Watkins JB. (2003). Diabetes, oxidative stress and antioxidants. Review, J Biochem Mol Toxic 17:4-38.
38. Morre DM, Lenaz G, Morre DJ. (2000). Surface oxidase and oxidative stress propagation in aging. J Exp Biol 203:1513-21.
39. Mylari BL, Oates PJ, Beebe DA, Brackett NS, Couther JB, Dina MS, Zembrowski WJ. (2001). Sorbitol dehydrogenase inhibitors (SDIs): a new potent, enantiomeric SDI, 4-[2-1R-hydroxyl-ethyl)-prymidin-4-yl]-piperazine-1-sulfonic acid dimethyamide. J Med Chem 44:2695-700.
40. Mylari BL, Oates PJ, Zembrowski WJ, Beebe DA, Conn EL, Couther JB, O'Gorman MT, Linhares MC, Withbroe GJ. (2002). A sorbitol dehydrogenase inhibitor of exceptional in vivo potency with a long duration of action:1-(R)-4-{4-(4, 6-dimethyl-[1, 3, 5]triazin-2-yl)-2R, 6S- dimethylpiperazin-1-yl]-pyrimidin 2-yl}-ethanol. J Med Chem 45:4398-401.
41. Mylari BL, Withbroe GJ, Beebe DA, Brackett NS, Conn EL, Coutcher JB, Oates PJ, Zembrowski WJ. (2003). Design and synthesis of a novel family of triazine-based inhibitors of sorbitol dehydrogenase with oral activity:1-{4-[3R, 5S-Dimethyl-4-(4-methyl-[1, 3, 5] triazin-2-yl)-piperazin-1-yl]-[1, 3, 5] triazin-2-yl}-(R) Ethanol. Bioorgan Med Chem 11:4179-88.
42. Negm FB, Loescher WH. (1979). Detection and characterization of sorbitol dehydrogenase from apple callus tissue. Plant Physiol 64:69-73.
43. O'Brien MM, Schofeld PJ, Edwards MR. (1983). Poliol pathway enzymes of human brain. Partial purifcation and properties of sorbitol dehydrogenase. Biochem J 211:81-90.
44. Oura Y, Yamada K, Shiratake K, Yamaki S. (2000). Purifcation and characterization of a NAD+dependent sorbitol dehydrogenase from Japanese pear fruit. Phytochemistry 54:567-72.
45. Pauly TA, Ekstrom JL, Beebe DA, Chrunyk B, Cunningham D, Grifor M, Kamath A, Lee SE, Madura R, McGuire D, et al. (2003). X-ray crystallographic and kinetic studies of human sorbitol dehydrogenase. Structure 11:1071-85.
46. Philippsen A, Schirmer T, Stein MA, Gifhorn F, Stetefeld J. (2005). Structure of zinc-independent sorbitol dehydrogenase from Rhodobacter sphaeroides at 2.4 A resolution. Acta Cryst 61:374-9.
47. Rehg JE, Torack RM. (1977). Partial purification and characterization of sorbitol dehydrogenase from rat brain. J Neurochem 28:655-60.
48. Söyüt H, Beydemir Ş, Hisar O. (2008). Efects of some metals on carbonic anhydrase from brains of rainbow trout. Biol Trace Elem Res 123:179-90.
49. Söyüt H, Beydemir Ş. (2011). Te impact of heavy metals on the activity of carbonic anhydrase from rainbow trout (Oncorhynchus mykiss) kidney. Toxicol Ind Health 28:296-305.
50. Stevens MJ, Obrosova I, Cao X, Van Husyen C, Grene DA. (2000). Efects of DL-α-lipoic acid on peripheral nerve conduction, blood fow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49:1006.
51. Szabó Z, Hämäläinen J, Loikkanen I, Moilanen AM, Hirvikoski P, Väisänen T, Paavonen TK, Vaarala MH. (2010). Sorbitol dehydrogenase expression is regulated by androgens in the human prostate. Oncology Reports 23:1233-9.
52. Tesfamariam B. (1994). Free radical in diabetic endothelial cell dysfunction. Free Radic Biol Med 16:383-91.
53. Tilton RG, Chang K, Nyengaard JR, van den Enden M, Ido Y, Williamson Jr. (1995). Inhibition of sorbitol dehydrogenase. Efects on vascular and neural dysfunction in streptozocin induced diabetic rats. Diabetes 44:234-42.
54. Wiesinger H, Hamprecht B. (1987). Purifcation and properties of sorbitol dehydrogenase from bovine brain. J Neurochem 48:147.
55. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van Den EM, Kilo C, Tilton RG. (1993). Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801.
56. Yabe-Nishimura C. (1998). Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacol Rev 50:21-33.
57. Yamaguchi H, Kanayama Y, Yamaki S. (1994). Purifcation and properties of NAD+dependent sorbitol dehydrogenase from apple fruit. Plant Cell Physiol 35:887-92.
58. Yeh LA, Ashton MA. (1990). Te increase in lipid peroxidation in diabetic rat lens can be reserved by oral sorbinil. Metabolism 39:619-22.
59. Yennawar H, Møller M, Gillilanb R, Yennawara N. (2011). X-ray crystal structure and small-angle X-ray scattering of sheep liver sorbitol dehydrogenase. Acta Cryst 67:440-46.
60. Yilmaz H, Ciftci M, Beydemir Ş, Bakan E. (2002). Purifcation of glucose 6-phosphate dehydrogenase from chicken erythrocytes. Investigation of some kinetic properties. Prep Biochem Biotech 32:287-301.